↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$363KSold on the market
1Companies
Sep 15, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202617:02 | Sep 14, 2026 | NBIXNEUROCRINE BIOSCIENCES INC | Chief Financial Officer | S · Sell10b5-1 | $157.20 | −2,311 | 42,808 | -5% | −$363K | ||
| Sep 15, 202617:02 | Sep 11, 2026 | NBIXNEUROCRINE BIOSCIENCES INC | Chief Financial Officer | F · Tax10b5-1 | $156.22 | −2,709 | 45,119 | -6% | $423K | ||
| Sep 15, 202617:02 | Sep 11, 2026 | NBIXNEUROCRINE BIOSCIENCES INC | Chief Financial Officer | A · Grant10b5-1 | — | +5,020 | 47,828 | +12% | — |